Alterity Therapeutics ATHE
NASDAQ ATHE
$2.42 -0.01 (-0.41%)
As of: Oct 21, 2026 · 11:31 AM EDT

Alterity Therapeutics (ATHE) Common Equity (2009 - 2026)

Updated

Alterity Therapeutics (ATHE) posted Common Equity of $30.31 million for the quarter ended Jun 30, 2026, up 11.6% from $27.16 million a year earlier.

Analysis

Alterity Therapeutics (ATHE) Common Equity (2009 - 2026) Analysis & Trends

Since the quarter ended Jun 30, 2009, Alterity Therapeutics has reported Common Equity for 34 quarters.

  • Annual Common Equity shows a five-year compound annual growth rate of 5.3% (years ended Jun 2021 to Jun 2026).
  • In prior years, Alterity Therapeutics' Common Equity was $27.16 million in the year ended Jun 30, 2025, $137,981 in the year ended Jun 30, 2024 (-39.5%), $228,129 in the year ended Jun 30, 2023 (-99.1%) and $25.41 million in the year ended Jun 30, 2022 (+8.3%).
  • Quarterly Common Equity has run from a low of $5.09 million in the quarter ended Dec 31, 2024 to a high of $35.63 million in the quarter ended Dec 31, 2025 over five years.
  • On a year-over-year basis, Common Equity increased in three of the last four quarters, with growth averaging 188.6%.
  • The strongest year-over-year quarter for Common Equity in the past five years was the quarter ended Dec 31, 2025, with growth of 599.8%; the weakest was the quarter ended Dec 31, 2024, with a decline of 55.6%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 84.97 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -5.94 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 50.37 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 11.83 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 85.49 Bn
10 Alterity Therapeutics 42.45 Mn -40.70 Mn - 29.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.41 Mn
Dec 31, 2025 36.35 Mn
Jun 30, 2025 27.70 Mn
Dec 31, 2024 4.84 Mn
Jun 30, 2024 9.18 Mn
Dec 31, 2023 12.03 Mn
Jun 30, 2023 15.10 Mn
Dec 31, 2022 19.01 Mn
Jun 30, 2022 24.40 Mn
Dec 31, 2021 29.82 Mn
Jun 30, 2021 22.89 Mn
Dec 31, 2020 26.42 Mn
Jun 30, 2020 4.91 Mn
Dec 31, 2019 7.84 Mn
Jun 30, 2019 11.59 Mn
Dec 31, 2018 7,695.03
Jun 30, 2018 11.81 Mn
Dec 31, 2017 15.68 Mn
Jun 30, 2017 18.21 Mn
Dec 31, 2016 19.94 Mn
API Access

Alterity Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=ATHE&period=max&api_key=YOUR_API_KEY